Mission
TO PROVIDE SUPPORT, ADVOCACY AND EDUCATION TO PATIENTS, FAMILIES, THE MEDICAL COMMUNITY AND THE PUBLIC ABOUT HYPERTROPHIC CARDIOMYOPATHY, WHILE SUPPORTING RESEARCH AND FOSTERING THE DEVELOPMENT OF TREATMENTS.
Public Charity
HYPERTROPHIC CARDIOMYOPATHY ASSOCIATION
Based in DENVILLE, NJ, HYPERTROPHIC CARDIOMYOPATHY ASSOCIATION operates as a Public Charity. The organization reported $2.0M in revenue, $1.4M in expenses, $2.0M in total assets for fiscal year 2024. Imperigo tracks 17 reported grant relationships connected to this organization totaling approximately $361K.
EIN: 411855605
DENVILLE, NJ
Latest filing: 2024
Total Revenue$2.0M
Total Expenses$1.4M
Total Assets$2.0M
Grant Records17
Funding Total$361K
Filing Years2020–2024
Sample Grants Received
GENERAL SUPPORT
$30,243
For grant recipient's exempt purposes
$20,895
IN FURTHERANCE OF GRANTEE'S TAX-EXEMPT PURPOSE
$150,000
For grant recipient's exempt purposes
$11,050
Showing up to 5 of 17 total records — full history available with membership.
Officers & Directors
SECRETARY
Adam Salberg
DIRECTOR
Amit Kalia Phd
DIRECTOR
Bill Rossi
DIRECTOR
Billur Dowse
CHAIR
Gordon Fox Phd
DIRECTOR
Isaac Rodriguez-Chavez Phd Mh
Officer compensation and complete director data available with membership.
Top Grant Purposes
Financial Trends
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2024 | $2.0M | $1.4M | $2.0M |
| 2023 | $1.3M | $1.1M | $1.4M |
| 2022 | $1.1M | $796K | $1.1M |
| 2021 | $805K | $532K | $577K |
| 2020 | $391K | $374K | $313K |
Between 2020 and 2024, reported annual revenue grew from $391K to $2.0M (+401%), with total assets most recently reported at $2.0M.
Interactive year-over-year charts and full filing details available with membership.